Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSTA4637S in healthy volunteers
NCT02596399Phase 1Completed
- Sponsor
- Genentech
- Start
- Nov 2015
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Staphylococcus aureus infection comparing DSTA4637S with Placebo (2 arms). Primary endpoint: Number of Participants with at least 1 Adverse Event. Started Nov 2015; status: completed.
02
Drugs
DSTA4637S
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT02596399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596399.